Bart C. Kuenen

Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors

Bart C. Kuenen · Journal of Clinical Oncology · 2002 · 252 citations

Analysis of Coagulation Cascade and Endothelial Cell Activation During Inhibition of Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Pathway in Cancer Patients

Bart C. Kuenen, Marcel Levi, Joost C.M. Meijers et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2002 · 149 citations · Full text

Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors

Bart C. Kuenen, Lee S. Rosen, Egbert F. Smit et al. · Journal of Clinical Oncology · 2002 · 128 citations

Solid Tumors, Medicine, Coagulation Cascade +10

Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcoma.

Bart C. Kuenen, Josep Tabernero, José Baselga et al. · PubMed · 2003 · 127 citations

Effect of Providing Cancer Patients With the Audiotaped Initial Consultation on Satisfaction, Recall, and Quality of Life: A Randomized, Double-Blind Study

L.M.L. Ong, Marja Visser, Frits B. Lammes et al. · Journal of Clinical Oncology · 2000 · 127 citations